not sure if it has already been mentioned ......... I am hearing WMN's new acquisition is a European cobalt project ....let's hope it follows in EQU's footsteps .WMN currently has a very low EV of around $2M so plenty of scope for a massive rerate
NTI Neurotech knocked back by FDA as agency declares target condition not rare enough for special status
